VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $602,000 | +336.2% | 25,917 | +107.1% | 0.23% | +303.5% |
| Q1 2017 | $138,000 | -24.2% | 12,517 | 0.0% | 0.06% | -31.3% |
| Q4 2016 | $182,000 | -40.7% | 12,517 | 0.0% | 0.08% | -38.1% |
| Q3 2016 | $307,000 | +21.8% | 12,517 | 0.0% | 0.13% | +26.4% |
| Q2 2016 | $252,000 | -23.4% | 12,517 | 0.0% | 0.11% | -28.4% |
| Q1 2016 | $329,000 | -74.1% | 12,517 | 0.0% | 0.15% | -75.3% |
| Q4 2015 | $1,272,000 | -68.8% | 12,517 | -22.0% | 0.60% | -64.4% |
| Q3 2015 | $4,081,000 | 0.0% | 16,050 | 0.0% | 1.68% | 0.0% |
| Q2 2015 | $4,081,000 | +12.3% | 16,050 | -12.3% | 1.68% | +105.8% |
| Q1 2015 | $3,635,000 | – | 18,300 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |